JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, R. M.
Right arrow Articles by Warpula, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, R. M.
Right arrow Articles by Warpula, R. W.
Journal of the American Podiatric Medical Association
Volume 94 Number 2 90-97 2004
Copyright © 2004 American Podiatric Medical Association

Geriatric Pharmacology

Safer Prescribing for the Elderly Patient

Rollin M. Wright, MD, MA * and Rick W. Warpula, DPM {dagger}

* Division of Geriatrics, Department of Medicine, Rhode Island Hospital and Brown Medical School, Providence, RI.
{dagger} The Woodlands Foot Health Center, The Woodlands, TX. Dr. Warpula is now in private practice, Merritt Island, FL.

Corresponding author: Rollin M. Wright, MD, MA, Division of Geriatrics, Department of Medicine, Rhode Island Hospital, 593 Eddy St, Providence, RI 02903.

Abstract

Adverse drug effects are common in elderly patients but can often be avoided. Judicious prescribing practices require the clinician to be aware of age-related changes in drug absorption, distribution, metabolism, and elimination. Clinicians may need to adjust drug dose, frequency, or the choice of drug altogether as they consider the physiologic changes of aging. This article reviews prescribing situations with elderly patients commonly encountered by the podiatric physician. Strategies for medication management are provided to minimize the risk of adverse drug events in the older patient. (J Am Podiatr Med Assoc 94(2): 90-97, 2004)




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
J. Meletiadis, S. Chanock, and T. J. Walsh
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
Clin. Microbiol. Rev., October 1, 2006; 19(4): 763 - 787.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Podiatric Medical Association.